0001179110-20-009902.txt : 20200921 0001179110-20-009902.hdr.sgml : 20200921 20200921175501 ACCESSION NUMBER: 0001179110-20-009902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200921 FILED AS OF DATE: 20200921 DATE AS OF CHANGE: 20200921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Friend Cynthia M CENTRAL INDEX KEY: 0001675108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 201187360 MAIL ADDRESS: STREET 1: C/O BRUKER CORPORATION STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 edgar.xml FORM 4 - X0306 4 2020-09-21 0 0001109354 BRUKER CORP BRKR 0001675108 Friend Cynthia M BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 1 0 0 0 Common Stock 2020-09-21 4 M 0 800 26.17 A 12657 D Common Stock 2020-09-21 4 S 0 800 37.5813 D 11857 D Stock Option (Right to Buy) 26.17 2020-09-21 4 M 0 800 0 D 2026-05-20 Common Stock 800 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.79, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested in three approximately equal annual installments on May 20, 2017, 2018 and 2019. /s/ Michael Rich, Attorney-in-Fact 2020-09-21